EUCTR2007-003077-44-IT进行中（未招募）不适用
EffectS of PiogLitazone on ENDOthelial progenitoR cells in type 2 diabetic patients with vascular complications - The SPLENDOR Study - SPLENDOR
TAKEDA0 个研究点开始时间: 2008年7月3日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •HbA1c>7,5% and <10%; age at onset of type 2 diabetes >35 years; metfomine monotherapy up to the maximum tolerated daily dose; one or more cardiovascular comorbidity.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •insulin therapy; severe obesity; evidence of systemic deseases; cardiovascular deseases as unstable angina, myocardial infarction, bypass or PTCA within 3 months of study entry, heart failure.
研究者
相似试验
已完成
不适用
Improvement effects of pioglitazone on endothelial function after sirolimus-eluting stent (Cypher stent) implantation: a randomized, open rabelled, prospective study.coronary artery diseaseJPRN-UMIN000000899Chiba University Graduate School of Medicine50
已完成
不适用
Effect of alogliptin/pioglitazone on endothelial function and Visceral fat of Type 2DiabetesType2 diabetesJPRN-UMIN000023463Dokkyo medical university hospital30
已完成
4 期
Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.Diabetes MellitusNCT00770835Takeda39
撤回
2 期
Endometriosis: ImmunomodulationEndometriosisNCT01184144University of Wisconsin, Madison
进行中（未招募）
1 期
The effect of Pioglitazone on vascular and ventricular function in people with type 2 diabetes PICCOLA - PICCOLADiabetesEUCTR2007-001222-27-GBImperial College London24